Apeiron Investment Group is the private investment firm of entrepreneur and investor Christian Angermayer who is also one of the co-founders at atai Life Sciences.
Apeiron Investment Group
Apeiron is currently managing over $3.5 billion in assets with a portfolio including over 100 companies located across North America, Europe and Asia. The group is focused on three overarching investment areas: Life Sciences, Crypto & FinTech and Future Tech. Some of their investments include atai Life Sciences, Cambrian Biopharma and Block.One.
Activities
B2B
Investor
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates